Both in Pharmaceuticals
Kairos Pharma vs Propanc Biopharma
Over the past year KAPA returned −91.9% and PPCB returned −99.3%; their daily moves had a correlation of 0.03.
KAPA −91.9% PPCB −99.3%Growth of $1, one year, split-adjusted
| Metric | KAPA | PPCB |
|---|---|---|
| Price | $0.4897 | $1.79 |
| Market cap | $1.7M | $1.8M |
| Today | −3.03% | +4.68% |
| 1 month | −57.4% | −63.6% |
| 6 months | −87.4% | −92.9% |
| Year to date | −90.1% | −98.7% |
| 1 year | −93.1% | −99.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $2.6M | $832.0K |
| Dividend yield | — | — |
| Volatility (60d) | 580.4% | 730.0% |
| Short % of float | 0.9% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).